| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 07/07/2011 | US20110165633 Production of Polyketides and Other Natural Products |
| 07/07/2011 | US20110165225 Modified Drugs for Use in Liposomal Nanoparticles |
| 07/07/2011 | US20110165120 Inhibitors of serine proteases |
| 07/07/2011 | CA2785679A1 1,3,4-oxadiazole-2-carboxamide compound |
| 07/06/2011 | EP2341052A1 Ring-fused morpholine derivative having pi3k-inhibiting activity |
| 07/06/2011 | EP2340830A2 Hepatitis C Virus Inhibitors |
| 07/06/2011 | EP2340244A1 Compounds and methods of use |
| 07/06/2011 | EP2340025A1 Cgrp receptor antagonists |
| 07/06/2011 | CN1893944B 3-cyano-quinoline derivatives with antiproliferative activity |
| 07/06/2011 | CN101585843B Process for preparing rifaximin |
| 07/06/2011 | CN101381365B Dual action antibiotics |
| 07/05/2011 | US7973050 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly |
| 07/05/2011 | US7973040 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors |
| 07/05/2011 | US7973036 2-methyl-5-imino-benzo[D][1 ,3]oxazin[5-B]pyrazole compound, preparation and use thereof |
| 07/05/2011 | US7973033 Multi-cyclic cinnamide derivatives |
| 07/05/2011 | US7973031 Leukemia therapy ;myelodyspastic syndrome |
| 07/05/2011 | US7973026 Thienopyrroles as antiviral agents |
| 06/30/2011 | WO2011079102A1 Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors |
| 06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
| 06/30/2011 | WO2011077098A1 Inhibitors of akt activity |
| 06/30/2011 | WO2011076744A1 Disubstituted heteroaryl-fused pyridines |
| 06/30/2011 | WO2011076687A1 Pyridinone derivatives and pharmaceutical compositions thereof |
| 06/30/2011 | WO2011048148A3 Glycoside derivative and uses thereof |
| 06/30/2011 | WO2011045265A3 Spirocyclic derivatives as histone deacetylase inhibitors |
| 06/30/2011 | WO2010110685A4 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| 06/30/2011 | US20110160452 2-Aminopyrimidine modulators of the histamine H4 receptor |
| 06/30/2011 | US20110160451 2-Aminopyrimidine modulators of the histamine H4 receptor |
| 06/30/2011 | US20110160448 Polymorphic forms alpha, beta and gamma of rifaximin |
| 06/30/2011 | US20110160198 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
| 06/30/2011 | US20110160197 Substituted Indoles and a Method for the Production and Use Thereof |
| 06/30/2011 | US20110158991 Cytotoxic agents comprising new maytansinoids |
| 06/30/2011 | CA2784894A1 Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors |
| 06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | CA2783340A1 Inhibitors of akt activity |
| 06/29/2011 | EP2337784A1 Macrocyclic compounds as hepatitis c virus inhibitors |
| 06/29/2011 | EP2337783A1 Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors |
| 06/29/2011 | CN101027301B Fused ring azadecalin glucocorticoid receptor modulators |
| 06/28/2011 | US7968593 Thiolactones |
| 06/28/2011 | US7968562 an immune response modifier (IRM) compound 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine; fatty acids such as oleic acid, isostearic acid; hydrophobic, aprotic caprylic/capric triglyceride miscible with fatty acid; actinic keratosis, postsurgical scars, warts, atopic dermatitis |
| 06/28/2011 | US7968541 Crystalline form of N-[[4-fluoro-2-(5-methyl-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-C][1,4]-oxazine-2-carboxamide, sodium salt monohydrate |
| 06/28/2011 | CA2602248C Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 06/28/2011 | CA2380305C Streptogramin derivatives, production thereof and compositions containing the same |
| 06/23/2011 | WO2011075615A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 06/23/2011 | WO2011075607A1 Novel inhibitors of hepatitis c virus replication |
| 06/23/2011 | WO2011073276A1 Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011073273A1 Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011051960A3 Process for producing rapamycin derivatives |
| 06/23/2011 | US20110152562 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING a-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME |
| 06/23/2011 | US20110152516 Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximin |
| 06/23/2011 | US20110152307 Ophthalmic composition comprising ascomycin |
| 06/23/2011 | US20110152239 10a-azalide compound having 4-membered ring structure |
| 06/23/2011 | US20110152234 Novel Compounds |
| 06/23/2011 | US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 06/23/2011 | US20110150827 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 06/23/2011 | CA2784748A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 06/22/2011 | EP2336136A1 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 06/22/2011 | EP2335700A1 Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| 06/22/2011 | EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors |
| 06/22/2011 | EP1994020B1 Substituted quinolones III |
| 06/22/2011 | CN102105469A Heterocyclic urea derivatives for the treatment of bacterial infections |
| 06/22/2011 | CN102105448A Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states |
| 06/22/2011 | CN102101866A Halogenated derivatives of staurosporine, and preparation method thereof and use thereof |
| 06/22/2011 | CN102101865A Crystal form of carbostyril compound hydrochlorides |
| 06/21/2011 | US7964723 And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate |
| 06/21/2011 | US7964624 Inhibitors of serine proteases |
| 06/21/2011 | US7964623 Tricyclic benzopyrane compound |
| 06/21/2011 | US7964622 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 06/21/2011 | US7964598 ApoE4 domain interaction inhibitors and methods of use thereof |
| 06/21/2011 | US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth |
| 06/21/2011 | CA2641379C Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 06/21/2011 | CA2516270C Oxadiazoline and thiadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
| 06/16/2011 | WO2011071135A1 Oxazine derivative |
| 06/16/2011 | WO2011071109A1 Fused heterocyclic compound having amino group |
| 06/16/2011 | WO2011070029A1 Amino oxazine derivatives |
| 06/16/2011 | WO2011069456A1 Divalent and oxabridged heterocyclic neonicotinoid compounds and preparation methods thereof |
| 06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
| 06/16/2011 | US20110144176 Macrolides and methods for producing same |
| 06/16/2011 | US20110142856 Compound containing basic group and use thereof |
| 06/16/2011 | US20110142796 Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibitors |
| 06/16/2011 | CA2783958A1 Oxazine derivative |
| 06/16/2011 | CA2783504A1 Divalent and oxabridged heterocyclic nicotine related compounds and preparation methods thereof |
| 06/16/2011 | CA2780693A1 Amino oxazine derivatives |
| 06/15/2011 | EP2333028A1 Photochromic compounds |
| 06/15/2011 | EP2332918A1 Sulfonamide derivatives of polycyclic dyes for analytical applications |
| 06/15/2011 | EP2331552A1 Hepatitis c virus inhibitors |
| 06/15/2011 | EP2331503A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 06/15/2011 | EP1784399B1 Pyrimidine derivatives |
| 06/15/2011 | CN102093389A Duplex and oxygen bridge heterlcyclic ring anabasine compound and preparation method thereof |
| 06/15/2011 | CN102093388A Method for preparing decarboxylated levofloxacin |
| 06/15/2011 | CN102093387A Crystal compound of 4,5,6,7-tetrahydro-isoxazolo[5,4-c]pyridine-3-alcohol-hydrate |
| 06/15/2011 | CN101596191B Method for treatment of disease using malonyl-coa decarboxylase inhibitor |
| 06/15/2011 | CN101253171B Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 06/15/2011 | CN101137660B Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 06/14/2011 | US7960405 Prodrug of Rapamycin analog; chemokine receptor antagonist; antiproliferative, antiinflammatory , anticarcinogenic agent, anticoagulant; autoimmune diseases; restenosis; stents, catheters, by-pass graft; drug delivery; balloon overcoated with drugs |
| 06/14/2011 | CA2548297C Process for the purification of macrolides |
| 06/14/2011 | CA2494962C Tyrosine kinase inhibitors |
| 06/14/2011 | CA2470037C Prodrugs to d-prolines |